Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
about
Induction therapy in heart transplantation: where are we now?Therapeutic options in post-transplant lymphoproliferative disorders.Plasmacytoma-like post-transplant lymphoproliferative disorder, a rare subtype of monomorphic B-cell post-transplant lymphoproliferation, is associated with a favorable outcome in localized as well as in advanced disease: a prospective analysis of 8Pulmonary complications of solid organ and hematopoietic stem cell transplantation.EBV-associated lymphoproliferative disorder of CNS associated with the use of mycophenolate mofetilMycophenolate mofetil in organ transplantation: focus on metabolism, safety and tolerability.Posttransplant lymphoproliferative disease after lung transplantation.Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation.An overview of the pathogenesis and natural history of post-transplant T-cell lymphoma (corrected and republished article originally printed in Leukemia & Lymphoma, June 2007; 48(6): 1237 - 1241).Matched-pair analysis: identification of factors with independent influence on the development of PTLD after kidney or liver transplantation.Post-transplant lymphoproliferative disorders in lung transplant recipients: 20-yr experience at the University of Minnesota.Posttransplant lymphoproliferative disease in liver transplant patients.Effect of maintenance immunosuppressive drugs on virus pathobiology: evidence and potential mechanisms.Post-transplant lymphoproliferative disease is associated with early sternotomy and left ventricular hypoplasia during infancy: a population-based retrospective review.A case of fulminant post-transplant lymphoproliferative disorder and septicemia.Malignancies after living-donor and cadaveric lung transplantations in Japanese patients.Post-transplant lymphoproliferative disorder (PTLD): single institutional experience of 141 patients.Remission of late-onset post-heart transplantation lymphoproliferative disorder following treatment with rituximab and modified mini-CHOP chemotherapy: A case report.Post-transplantation lymphoproliferative disease: Epstein-Barr virus DNA levels, HLA-A3, and survival.Mycophenolate mofetil vs. azathioprine is associated with decreased acute rejection, late acute rejection, and risk for cardiovascular death in renal transplant recipients with pre-transplant diabetes.Malignancy after heart transplantation: incidence, prognosis and risk factors.Mutlifocal osseous posttransplantation lymphoproliferative disorder: case report.Increased Incidence of Post-transplant Lymphoproliferative Disorder in Autoimmune Liver Disease: An Irish National Experience.Posttransplant Lymphoproliferative Disorder after Cardiac Transplantation in Children: Life Threatening Complications Associated with Chemotherapy Combined with Rituximab
P2860
Q26999269-07F1DF1B-8984-41CF-B775-573D6D6BDDA1Q30455714-9898C9CF-1F43-4041-BFFF-02B22075A907Q35082545-1635AB90-1EB0-4C3E-B59C-36E26A15744EQ35740698-9A7F054F-21A0-481B-B03F-DA37BD629876Q35870511-9B898A4E-1979-4172-9C05-DA08C23BAED7Q36544988-74DDE54A-62EB-44F3-B52F-85DAAEB4E159Q36701511-8E2EB4D5-821A-4388-A55F-899AEF5273C5Q36732580-211917EB-CD33-4B75-9EF0-D358DA893BC1Q36929679-713DDCC6-188F-4D7E-BCE7-29960FC30BE8Q37145738-7A0A3C96-4E28-4AAE-BDBD-06948B49F209Q37809559-9805DEE8-48FF-4B28-9033-26E35C6CD966Q37838795-367C8471-EC1F-4A99-8DA1-15F4B522E710Q38061056-5A8791EC-23E4-4C76-A8AB-1E78414F2EFFQ40093152-2DA17BDD-5502-446E-963D-7CA9C73AEBBEQ40480387-FAE21546-A2AE-44CF-AF8F-93519D8941A6Q40496068-9486DC28-A5B3-4A0B-B42D-CF3238EE5D25Q42368054-F9B91E6C-B865-4278-A472-5B21F943ADC0Q42720674-A73CD9EE-05C3-4919-BC13-0210084206F3Q43407559-28F4C9E0-1C8D-47CA-8770-541E7F3FE2A5Q45289903-36B2A71C-8FDF-45B3-A3FD-A51EFE16B3C5Q45717051-C03813FD-55A1-4270-9C14-15C5BD080803Q47572467-2322BE93-ADDC-4C2B-A285-2B73ADA93DE4Q53684074-AF619982-C6FA-4412-B7E5-673E2D288A2DQ58998353-BA0C46CE-625E-4CBF-89D1-7E38AAC188EE
P2860
Post-transplantation lymphoproliferative disease in heart and heart-lung transplant recipients: 30-year experience at Stanford University.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Post-transplantation lymphopro ...... rience at Stanford University.
@en
Post-transplantation lymphopro ...... rience at Stanford University.
@nl
type
label
Post-transplantation lymphopro ...... rience at Stanford University.
@en
Post-transplantation lymphopro ...... rience at Stanford University.
@nl
prefLabel
Post-transplantation lymphopro ...... rience at Stanford University.
@en
Post-transplantation lymphopro ...... rience at Stanford University.
@nl
P2093
P1476
Post-transplantation lymphopro ...... rience at Stanford University.
@en
P2093
Joan L Miller
John Schroeder
Jose G Montoya
Mark Perlroth
Phillip E Oyer
Sandra V Chaparro
Shao-Zhou Gao
Sue DiMiceli
P304
P356
10.1016/S1053-2498(02)01229-9
P577
2003-05-01T00:00:00Z